Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
CM082 tablet
DRUG
2 trials
Sponsors
AnewPharma
Conditions
Advanced Cancer
Age-Related Macular Degeneration
Phase 1
Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China
Completed
NCT01863485
AnewPharma
Advanced Cancer
Start: 2013-05-31
End: 2016-05-31
Updated: 2019-07-05
Phase 1 Study of CM082 in Patients With wAMD
Suspended
NCT02452385
AnewPharma
Age-Related Macular Degeneration
Start: 2015-03-31
End: 2020-06-30
Target: 56
Updated: 2020-01-13
Related Papers
Vorolanib (CM082) in Chinese patients with advanced solid tumor: A phase 1, open-label, dose escalation study.
Journal of Clinical Oncology
2018-05-20
1 citations